| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash flows provided by financing activities | 3,335,240 | 327,222 |
| Net change in cash | -191,392 | -2,102,456 |
| Cash and cash equivalents at beginning of period | 2,832,931 | - |
| Cash and cash equivalents at end of period | 2,641,539 | - |
MIRA PHARMACEUTICALS, INC. (MIRA)
MIRA PHARMACEUTICALS, INC. (MIRA)